ストックスクリーナーアプリを入手
1.27
9.48%
0.11
Clearside Biomedical Inc (CLSD) 最新ニュース
Wall Street SWOT: Clearside Biomedical stock eyes ODYSSEY trial success - Investing.com
Armistice Capital LLC Has $2.78 Million Holdings in Clearside Biomedical, Inc. (NASDAQ:CLSD) - MarketBeat
CLSD’s Stock Market Journey: A Year of Growth, Decline, and Uncertainty - The InvestChronicle
Financial Health Report: Clearside Biomedical Inc (CLSD)’s Ratios Tell a Tale - The Dwinnex
Can Clearside's ODYSSEY Trial Data Delight Investors? - RTTNews
CLSD’s Stock Market Adventure: 5.13% YTD Growth Amidst Volatility - The InvestChronicle
Nothing is Better Than Clearside Biomedical Inc (CLSD) stock at the moment - SETE News
Clearside Biomedical, Inc. (NASDAQ:CLSD) Sees Large Increase in Short Interest - MarketBeat
Clearside Biomedical Inc [CLSD] Shares Rise 3.05 % on Thursday - Knox Daily
Was anything positive for Clearside Biomedical Inc (CLSD) stock last session? - US Post News
Clearside Biomedical Inc (CLSD) Stock: Navigating a Year of Volatility - The InvestChronicle
The Attractiveness of Investing In Clearside Biomedical Inc (CLSD) is Growing - Knox Daily
Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives Average Rating of "Buy" from Brokerages - MarketBeat
International Assets Investment Management LLC Has $26,000 Holdings in Clearside Biomedical, Inc. (NASDAQ:CLSD) - Defense World
Clearside Biomedical (NASDAQ:CLSD) Share Price Crosses Below Fifty Day Moving Average of $1.12 - MarketBeat
Market Resilience: Clearside Biomedical Inc (CLSD) Finishes Weak at 0.93, Down -3.40 - The Dwinnex
Analysts review Clearside Biomedical Inc’s rating - Knox Daily
Clearside Slips on Trials - MSN
Clearside Biomedical Inc [CLSD] Investment Guide: What You Need to Know - Knox Daily
Quarterly Metrics: Quick and Current Ratios for Clearside Biomedical Inc (CLSD) - The Dwinnex
Clearside Biomedical (NASDAQ:CLSD) Given Buy Rating at HC Wainwright - Defense World
Clearside Biomedical (NASDAQ:CLSD) Receives Buy Rating from HC Wainwright - MarketBeat
Jones Trading maintains stock target, buy rating on Clearside Biomedical By Investing.com - Investing.com Canada
Jones Trading maintains stock target, buy rating on Clearside Biomedical By Investing.com - Investing.com UK
Clearside Slips on Trials - Baystreet.ca
Clearside Biomedical Announces Completion of Final - GlobeNewswire
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD - StockTitan
Assenagon Asset Management S.A. Buys Shares of 283,193 Clearside Biomedical, Inc. (NASDAQ:CLSD) - Defense World
Brokers Issue Forecasts for Clearside Biomedical, Inc.'s FY2024 Earnings (NASDAQ:CLSD) - MarketBeat
Brokers Issue Forecasts for Clearside Biomedical, Inc.’s FY2024 Earnings (NASDAQ:CLSD) - Defense World
Assenagon Asset Management S.A. Takes $368,000 Position in Clearside Biomedical, Inc. (NASDAQ:CLSD) - MarketBeat
Clearside Biomedical (NASDAQ:CLSD) Earns Buy Rating from Analysts at Chardan Capital - MarketBeat
Clearside Biomedical (NASDAQ:CLSD) Research Coverage Started at Chardan Capital - Defense World
Clearside Biomedical, Inc. (NASDAQ:CLSD) Shares Bought by Vanguard Group Inc. - Defense World
Clearside Biomedical (CLSD) Stock Price, News & Analysis - MarketBeat
Clearside Biomedical, Inc. (NASDAQ:CLSD) to Post Q3 2024 Earnings of ($0.13) Per Share, HC Wainwright Forecasts - Defense World
Q3 2024 EPS Estimates for Clearside Biomedical, Inc. (NASDAQ:CLSD) Increased by Analyst - MarketBeat
Oppenheimer gives an Outperform recommendation for Clearside Biomedical Inc (CLSD) - Knox Daily
Clearside Biomedical (NASDAQ:CLSD) Receives “Buy” Rating from HC Wainwright - Defense World
Clearside Biomedical (NASDAQ:CLSD) Issues Quarterly Earnings Results, Beats Estimates By $0.04 EPS - Defense World
Clearside Biomedical, Inc. (NASDAQ:CLSD) Short Interest Up 76.8% in July - Defense World
Clearside Biomedical, Inc. (NASDAQ:CLSD) Short Interest Up 76.8% in July - MarketBeat
Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives $4.60 Consensus Price Target from Analysts - MarketBeat
Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Clearside Biomedical (NASDAQ:CLSD) Earns Buy Rating from Needham & Company LLC - MarketBeat
Clearside Biomedical (NASDAQ:CLSD) Posts Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Clearside Biomedical (NASDAQ:CLSD) Given Buy Rating at Needham & Company LLC - Defense World
CLSD Stock Earnings: Clearside Biomedical Beats EPS, Misses Revenue for Q2 2024 - InvestorPlace
Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update - wallstreet:online
Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update - StockTitan
Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance
Wet Age-Related Macular Degeneration Pipeline 2024 | OliX Pharmaceuticals, Frontera Therapeutics, Kyowa Kirin, Boehringer Ingelheim, Clearside Biomedical, PanOptica, EyePoint Pharmaceuticals - Barchart
Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - ForexTV.com
Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - GlobeNewswire
Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - StockTitan
Clearside Biomedical Inc (CLSD) receives an Outperform rating from Oppenheimer - Knox Daily
Clearside Biomedical (CLSD) Scheduled to Post Earnings on Monday - MarketBeat
Clearside Biomedical (CLSD) Set to Announce Quarterly Earnings on Monday - Defense World
Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Canada Finance
Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024 - GlobeNewswire
Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024 - StockTitan
Clearside Biomedical Inc [CLSD] Stock Bought by Insider Chong Ngai Hang Victor for $24910.0 - Knox Daily
SG Americas Securities LLC Invests $49,000 in Clearside Biomedical, Inc. (NASDAQ:CLSD) - Defense World
Clearside Biomedical Inc (CLSD) requires closer examination - US Post News
0.05%
4.86%
大文字化:
|
ボリューム (24 時間):